Tulsi Therapeutics
PrivateLast Round
Grant
Jun 1, 2022
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Tulsi Therapeutics is a biotechnology company that specializes in the research, development, and manufacturing of stem cell and exosome-based regenerative medicine products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tulsi Therapeutics Comparables
Compare Tulsi Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HepaTx Corporation | 80% | |
| Morphocell Technologies | 77% | |
| Stempeutics Research | 64% | |
Tulsi Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2022 |
Tulsi Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| ASPIRE-BioNEST | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
Grew 42% QoQ, from 12 to 17 employees.
- May 22, 2026
Grew 33% QoQ from 9 to 12 employees.
Tulsi Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tulsi Therapeutics's valuation, stock price, and market status.